Severe morbidity as an important concept in the fight for women

Though we focus on maternal mortality and maternal death, in many settings, 'near misses' are equally important as both a public health concept and a human rights issue. The 'near miss' in obstetrics refers to a woman who was critically ill and would have died had it not been for care. Severe acute maternal morbidity (SAMM) in low-income countries.

Put another way, in looking at the health system, it is important to identify what factors led to death, and what factors helped narrowly avert death. In assessing the efficacy of a safe motherhood system, policymakers must look at the prevalence of near misses-- a decrease in the number of maternal deaths accompanied by an increase in severe acute maternal morbidity is of concern.

The rate of severe acute maternal mortality was found to be [.80% – 8.23% in studies that use disease-specific criteria while the range is 0.38% – 1.09% in the group that use organ-system based criteria and included unselected group of women] (http://www.reproductive-health-journal.com/content/1/1/3)

In a recent paper, Ronsmans and team studies a range of SAMM studies and noted that "is clearly illustrated in the studies that more SAMM cases are likely to die in resource-poor settings than in more developed country settings. For example, the studies conducted in Niger, Benin and Malaysia give the morbidity to mortality ratio as 11–12 [10,15,17] while this is 117–223 in studies conducted in Europe [11,18] in the category where disease-specific criteria are used. The same applies to the category of organ-system based criteria; morbidity: mortality ratio is 5–8 in South Africa [1,14,15] and 49 in Scotland [8]. These findings suggest that an indicator that relates SAMM to maternal deaths could be a useful method in assessing the care SAMM cases receive."

Leave a comment

Comments will be approved before showing up.


Also in The Maternova Blog

Benefits of intravenous iron to treat anemia in pregnancy
Benefits of intravenous iron to treat anemia in pregnancy

March 19, 2024 5 min read

Read More
A Point of Care Bilirubinometer Using Blood: BiliDx
A Point of Care Bilirubinometer Using Blood: BiliDx

January 16, 2024 2 min read

The BiliDx is a novel system for diagnosing jaundice.  The device uniquely meets the Target Product Profile (TPP) developed as part of the NEST 360 initiative in that it allows blood-based testing at the bedside.   This initiative is part of an emerging global consensus in the Every Newborn Action Plan that countries need functional WHO level-2 inpatient units to care for "small and sick newborns." 
Read More
NASG as a life-saving medical device to stabilize women with postpartum hemorrhage
Clinical Indications for Applying (and Removing) the NASG: Rule of 20

January 15, 2024 2 min read

The garment must be removed upon reaching hemodynamic stability for at least two hours, where it is evident:

  • Blood loss less than 50 mL/hour
  • Pulse less than 100 beats per minute
Read More